Cognition Therapeutics INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Pathstone Family Office, LLC has filed a Schedule 13G indicating zero beneficial ownership of common stock in Cognition Therapeutics Inc.